2021
COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects
RIAD, Abanoub; Holger SCHÜNEMANN; Sameh ATTIA; Tina POKLEPOVIĆ PERIČIĆ; Marija Franka ŽULJEVIĆ et al.Základní údaje
Originální název
COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects
Autoři
RIAD, Abanoub; Holger SCHÜNEMANN; Sameh ATTIA; Tina POKLEPOVIĆ PERIČIĆ; Marija Franka ŽULJEVIĆ; Mikk JÜRISSON; Ruth KALDA; Katrin LANG; Sudhakar MORANKAR; Elias Ali YESUF; Mohamed MEKHEMAR; Anthony DANSO-APPIAH; Ahmad SOFI-MAHMUDI; Giordano PÉREZ-GAXIOLA; Arkadiusz DZIEDZIC; João APÓSTOLO; Daniela CARDOSO; Janja MARC; Mayte MORENO-CASBAS; Charles Shey WIYSONGE; Amir QASEEM; Anna GRYSCHEK; Ivana TADIĆ; Mohammad Salman HUSSAIN; Mohammed Ahmed KHAN; Jitka KLUGAROVÁ; Andrea POKORNÁ; Michal KOŠČÍK a Miloslav KLUGAR
Vydání
International Journal of Environmental Research and Public Health, Basel, MDPI, 2021, 1660-4601
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30304 Public and environmental health
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.614
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/21:00122061
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
cohort studies; cross-sectional studies; COVID-19; drug-related side effects and adverse reactions; health personnel; mass vaccination; prevalence
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 12. 12. 2022 13:40, Mgr. Tereza Miškechová
Anotace
V originále
Background: Coronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. Methods: A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses’ side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869. Conclusions: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.
Návaznosti
| MUNI/A/1608/2020, interní kód MU |
| ||
| MUNI/IGA/1543/2020, interní kód MU |
|